Tarl W. Prow
- Pharmaceutical Science top 0.1%
- Dermatology top 0.2%
- Molecular Biology top 10%
- Biomedical Engineering top 5%
- Materials Chemistry top 10%
- Co-authors
- Michael S. RobertsMiko YamadaH. Peter SoyerJeffrey E. GriceLynlee L. LinXianfeng ChenAnthony P. RaphaelM. A. F. Kendall
- Topics
- Advancements in Transdermal Drug Delivery (33 papers)Cutaneous Melanoma Detection and Management (25 papers)Skin Protection and Aging (20 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Tarl W. Prow
122 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Pharmaceutical Science 1.5k
- Dermatology 1.2k
- Molecular Biology 957
- Biomedical Engineering 821
- Materials Chemistry 525
Countries citing papers authored by Tarl W. Prow
This map shows the geographic impact of Tarl W. Prow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarl W. Prow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarl W. Prow more than expected).
Fields of papers citing papers by Tarl W. Prow
This network shows the impact of papers produced by Tarl W. Prow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarl W. Prow. The network helps show where Tarl W. Prow may publish in the future.
Co-authorship network of co-authors of Tarl W. Prow
This figure shows the co-authorship network connecting the top 25 collaborators of Tarl W. Prow. A scholar is included among the top collaborators of Tarl W. Prow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarl W. Prow. Tarl W. Prow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 9 | |
| 5 | Health-related toxicity of emerging per- and polyfluoroalkyl substances: Comparison to legacy PFOS and PFOAbreakdown → | 189 |
| 6 | 25 | |
| 7 | 19 | |
| 8 | 12 | |
| 9 | 38 | |
| 10 | 10 | |
| 11 | 8 | |
| 12 | 13 | |
| 13 | 71 | |
| 14 | Comparative analysis of UV-induced DNA damage and metabolic deterioration in skin by gamma-H2AX immunohistochemistry and NAD(P)H imaging | 1 |
| 15 | Non-invasive assessment of skin ageing | 2 |
| 16 | Nanoparticles and microparticles for skin drug deliverybreakdown → | 610 |
| 17 | 19 | |
| 18 | Characterization of Vascular Precursors in Developing Human Retina | 2 |
| 19 | 3 | |
| 20 | Development of a novel targeted nanoparticle gene therapy strategy for the treatment of hepatitis C virus infection | 1 |
About Tarl W. Prow
Tarl W. Prow is a scholar working on Pharmaceutical Science, Dermatology and Biophysics, having authored 127 papers that have together received 4.5k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (33 papers), Cutaneous Melanoma Detection and Management (25 papers) and Skin Protection and Aging (20 papers). The work is most often cited by research in Pharmaceutical Science (1.5k citations), Dermatology (1.2k citations) and Biophysics (353 citations). Tarl W. Prow has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Michael S. Roberts, Miko Yamada, H. Peter Soyer, Jeffrey E. Grice, Lynlee L. Lin, Xianfeng Chen, Anthony P. Raphael, M. A. F. Kendall, Germain J. P. Fernando and Michael L. Crichton. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.